Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Current Leases (2023 - 2025)

Metagenomi (MGX) has disclosed Current Leases for 3 consecutive years, with $6.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 7.74% to $6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.0 million, a 7.74% increase, with the full-year FY2025 number at $6.0 million, up 7.74% from a year prior.
  • Current Leases was $6.0 million for Q4 2025 at Metagenomi, up from $5.6 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $6.0 million in Q4 2025 to a low of $3.4 million in Q4 2023.
  • A 3-year average of $5.1 million and a median of $5.5 million in 2025 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: soared 63.17% in 2024, then grew 2.08% in 2025.
  • Metagenomi's Current Leases stood at $3.4 million in 2023, then skyrocketed by 63.17% to $5.6 million in 2024, then grew by 7.74% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Current Leases are $6.0 million (Q4 2025), $5.6 million (Q3 2025), and $5.5 million (Q2 2025).